Personalized Healthcare and Its Impact on the Blood Grouping Reagents Market
Personalized healthcare is increasing the demand for accurate blood typing, boosting the Blood Grouping Reagents Market. Blood grouping reagents play a critical role in transfusion safety, organ transplantation, and prenatal diagnostics.
Hospitals, diagnostic labs, and blood banks are adopting advanced automated systems to provide faster and reliable results, supporting individualized patient care and improving treatment outcomes.
Market Outlook: Valued at USD 1.2 billion in 2024, the market is expected to reach USD 2.5 billion by 2034, growing at a 7.1% CAGR.
1 vista